GET THE APP

Cytokine Dysregulation in Wound Healing: Impact of Infections and Chronic Conditions
Reach Us +44-74-1148-3554

Commentary - Journal of Molecular Pathophysiology (2024)

Cytokine Dysregulation in Wound Healing: Impact of Infections and Chronic Conditions

Eamon Archer*
 
Department of Dermatology, Stanford University, Palo Alto, USA
 
*Corresponding Author:

Eamon Archer, Department of Dermatology, Stanford University, Palo Alto, USA, Email: eamon999@yahoo.com

Received: 18-Dec-2023, Manuscript No. JMOLPAT-24-126699; Editor assigned: 21-Dec-2023, Pre QC No. JMOLPAT-24-126699 (PQ); Reviewed: 05-Jan-2024, QC No. JMOLPAT-24-126699; Revised: 12-Jan-2024, Manuscript No. JMOLPAT-24-126699 (R); Published: 19-Jan-2024

About the Study

Wound healing is a complex and dynamic process that involves a series of intricate cellular and molecular events aimed at restoring the structural and functional integrity of damaged tissue. This physiological response is essential for the maintenance of tissue homeostasis and the prevention of infections. The pathophysiology of wound healing can be broadly categorized into three main phases. They are inflammation, proliferation, and remodelling. Every stage is distinguished by a distinct collection of molecular and biochemical processes that combine to ensure effective tissue restoration. The initial phase of wound healing is inflammation, a strictly controlled and really well-planned process that begins immediately after tissue injury. The primary purpose of inflammation is to control bleeding, remove debris, and initiate the repair process [1]. Upon injury, blood vessels constrict momentarily to minimize blood loss, followed by the rapid dilation of nearby blood vessels. This allows immune cells, such as neutrophils and macrophages, to migrate to the region of injury, where they play crucial roles in eliminating pathogens and cellular debris.

Inflammatory cells release various mediators, including cytokines and growth factors, which serve as signaling molecules to coordinate the activities of different cell types involved in wound healing. One key cytokine is Tumor Necrosis Factor-Alpha (TNF-α), which promotes inflammation by activating immune cells and enhancing their ability to eliminate foreign invaders [2]. Additionally, interleukins such as IL-1 and IL-6 contribute to the recruitment and activation of immune cells, further amplifying the inflammatory response. The inflammatory phase provides way to the proliferative phase, which is characterized by the beginning of tissue healing mechanisms.

Fibroblasts, in this phase, move to the wound area and begin synthesizing Extra Cellular Matrix (ECM) components, including collagen and fibronectin [3,4]. Collagen, in particular, provides structural support to the healing tissue and contributes to wound strength. Angiogenesis, the formation of new blood vessels, is another crucial occurrence during the proliferative phase. This process is stimulated by growth factors such as Vascular Endothelial Growth Factor (VEGF) and Fibroblast Growth Factor (FGF). The newly formed blood vessels supply nutrients and oxygen to the healing tissue, facilitating the ongoing repair processes [5].

In order to create a barrier of protection, epithelial cells near the outer edges of the wound begin to multiply and move across the surface of the wound at the same time. This epithelialization is essential for sealing the wound and preventing infection [6]. Keratinocytes, the predominant cell type in the epidermis, play a pivotal role in this process, guided by growth factors like Epidermal Growth Factor (EGF) and Transforming Growth Factor-Beta (TGF-β). The final phase of wound healing is remodelling, where the newly formed tissue undergoes structural refinement and maturation. Collagen, initially deposited in a disorganized manner, is rearranged and cross-linked to enhance tensile strength [7]. Matrix Metallo Proteinases (MMPs) are enzymes involved in collagen degradation and remodelling. The balance between MMPs and Tissue Inhibitors of Metalloproteinases (TIMPs) is crucial for proper tissue remodeling and scar formation. During the remodeling phase, the wound undergoes contraction, reducing its size. Myofibroblasts, specialized fibroblasts with contractile properties, play a central role in this process [8,9]. The amount of blood vessels reduces and the inflammatory reaction lessens as the wound heals. The end product is repaired tissue that still has structural and functional integrity but is not exactly like the original.

Several factors can influence the pathophysiology of wound healing. Chronic conditions like diabetes and autoimmune disorders, as well as systemic factors such as age and nutritional status, can impair the normal healing process. In diabetic individuals, for example, impaired vascularization and reduced immune function can lead to delayed wound healing and an increased risk of infections. Furthermore, the presence of infection at the wound area can significantly impact the healing process [10]. Infections prolong the inflammatory phase, disrupt the normal balance of cytokines, and impede cell migration and proliferation. Effective management of infections through antimicrobial interventions is crucial for promoting optimal wound healing.

References